ID   90.74
AC   CVCL_6361
DR   CLO; CLO_0001528
DR   ATCC; CRL-11654
DR   Wikidata; Q54605633
RX   Patent=US5858740;
RX   Patent=US6218187;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11654.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-11654; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
RX   Patent=US5858740;
RA   Finer, Mitchell H.
RA   Roberts, Margo R.
RA   Dull, Thomas J.
RA   Zsebo, Krisztina Maria
RA   Qin, Lu
RA   Farson, Deborah Ann
RT   "Method for production of high titer virus and high efficiency
RT   retroviral mediated transduction of mammalian cells.";
RL   Patent number US5858740, 12-Jan-1999.
//
RX   Patent=US6218187;
RA   Finer, Mitchell H.
RA   Dull, Thomas J.
RA   Zsebo, Krisztina Maria
RA   Cooke, Keegan
RA   Farson, Deborah Ann
RT   "Method for production of high titer virus and high efficiency
RT   retroviral mediated transduction of mammalian cells.";
RL   Patent number US6218187, 17-Apr-2001.
//